Moderna up another 8% as shorts bloodied

Apr. 08, 2019 11:02 AM ETModerna, Inc. (MRNA)MRNA, SNYBy: Douglas W. House, SA News Editor10 Comments
  • Short sellers in Moderna (MRNA +7.7%) are wondering where the peak is in the messenger RNA (mRNA) therapeutics developer. Shares have rallied 44% since April 2. According to FINRA, short interest has jumped over 22% to 11.44M shares.
  • Fellow mRNA player Translate Bio (TBIO +4.8%) is up as well, albeit on below-average volume.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.